1. Home
  2. Polycythemia Vera (PV)
  3. What is polycythemia vera (PV)? — Expert Video
Understanding and Diagnosing Polycythemia Vera (PV) — Animation
Understanding and Diagnosing Polycythemia Vera (PV) — Animation
Managing and Treating Polycythemia Vera (PV) — Animation
Managing and Treating Polycythemia Vera (PV) — Animation
Understanding and Diagnosing Polycythemia Vera (PV) — Slide Show
Understanding and Diagnosing Polycythemia Vera (PV) — Slide Show
Managing and Treating Polycythemia Vera (PV) — Slide Show
Managing and Treating Polycythemia Vera (PV) — Slide Show
Expert Videos
What is polycythemia vera (PV)?
1. What is polycythemia vera (PV)?
Why and how did my polycythemia vera (PV) arise?
2. Why and how did my polycythemia vera (PV) arise?
How is polycythemia vera (PV) diagnosed?
3. How is polycythemia vera (PV) diagnosed?
What are the signs, symptoms, and expectations of living with PV?
4. What are the signs, symptoms, and expectations of living with PV?
What are the risks with polycythemia vera (PV)?
5. What are the risks with polycythemia vera (PV)?
How is polycythemia vera (PV) managed and treated?
6. How is polycythemia vera (PV) managed and treated?
Patient Videos
Dana's story: How did you find out you had polycythemia vera (PV)?
7. Dana's story: How did you find out you had polycythemia vera (PV)?
Dana's story: What challenges and successes have you had with PV treatment?
8. Dana's story: What challenges and successes have you had with PV treatment?
Dana's story: What advice do you have for others on their journey with PV?
9. Dana's story: What advice do you have for others on their journey with PV?

What is polycythemia vera (PV)? — Expert Video

Dr. John Mascarenhas, Professor of Medicine at the Icahn School of Medicine at Mount Sinai, explains that polycythemia vera (PV) is a type of blood cancer in which the bone marrow overproduces red blood cells. He discusses the risks, including blood clots, bleeding, an enlarged spleen, and, for some patients, progression to myelofibrosis. Dr. Mascarenhas also explains that PV is a rare disease, affecting fewer than four people per 100,000.

  • Share with family and friends:

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about myeloproliferative neoplasms which will help other patients, caregivers, and families.

Other Modules:

Understanding MPNs

Understanding MPNs

Essential Thrombocythemia (ET)

Essential Thrombocythemia (ET)

Myelofibrosis (MF)

Myelofibrosis (MF)

Understanding and Diagnosing Polycythemia Vera (PV) — Animation
Understanding and Diagnosing Polycythemia Vera (PV) — Animation
Managing and Treating Polycythemia Vera (PV) — Animation
Managing and Treating Polycythemia Vera (PV) — Animation
Understanding and Diagnosing Polycythemia Vera (PV) — Slide Show
Understanding and Diagnosing Polycythemia Vera (PV) — Slide Show
Managing and Treating Polycythemia Vera (PV) — Slide Show
Managing and Treating Polycythemia Vera (PV) — Slide Show
Expert Videos
What is polycythemia vera (PV)?
1. What is polycythemia vera (PV)?
Why and how did my polycythemia vera (PV) arise?
2. Why and how did my polycythemia vera (PV) arise?
How is polycythemia vera (PV) diagnosed?
3. How is polycythemia vera (PV) diagnosed?
What are the signs, symptoms, and expectations of living with PV?
4. What are the signs, symptoms, and expectations of living with PV?
What are the risks with polycythemia vera (PV)?
5. What are the risks with polycythemia vera (PV)?
How is polycythemia vera (PV) managed and treated?
6. How is polycythemia vera (PV) managed and treated?
Patient Videos
Dana's story: How did you find out you had polycythemia vera (PV)?
7. Dana's story: How did you find out you had polycythemia vera (PV)?
Dana's story: What challenges and successes have you had with PV treatment?
8. Dana's story: What challenges and successes have you had with PV treatment?
Dana's story: What advice do you have for others on their journey with PV?
9. Dana's story: What advice do you have for others on their journey with PV?

Other Modules:

Understanding MPNs

Understanding MPNs

Essential Thrombocythemia (ET)

Essential Thrombocythemia (ET)

Myelofibrosis (MF)

Myelofibrosis (MF)

 

This educational activity has been developed by MPN Research Foundation in collaboration with Mechanisms in Medicine Inc.

This activity is supported by independent educational grants from Disc Medicine, GSK, Incyte, Merck, PharmaEssentia, Sumitomo Pharma, and Takeda.

We are also deeply grateful to the individual donors whose generosity supports the MPN Research Foundation's mission and programs like this one.

Thank you to the funders of You And MPN. All content is developed independently by MPN Research Foundation and Mechanisms in Medicine Inc., in collaboration with an Expert Faculty group; funders are allowed no influence on the content of You And MPN: Animated Patient® Guide to Myeloproliferative Neoplasms.

Disclaimer: The information provided is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always consult your doctor about any questions you may have regarding a medical condition. The visuals provided are meant to be representations only. No specific brand is being promoted or endorsed.

Copyright © Mechanisms in Medicine Inc. All rights reserved.

This website is part of the Animated Patient® series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.